CereVasc opens new manufacturing and R&D facility in Wilmington, Massachusetts

CereVasc opened a new manufacturing and research facility in Wilmington, Massachusetts, including an ISO Class 7 clean room, to support potential commercialisation of the eShunt System after completing STRIDE trial enrollment and an $85 million Series C financing.

“This facility is an investment in CereVasc's future.”cerevasc.com

• 1 source
• cerevasc.comCereVasc Opens New Massachusetts Facility in Preparation for eShunt® System Commercialization | CereVasc | Neurological Disease Device CompanyCarlos BonillaJul 30, 2026

Summarized from public sources; check the original articles before acting on it.